PHARM.ASPHARM.ASAMS
Loading
EBITDA Over TimeContracting
Percentile Rank64
3Y CAGR-35.4%
5Y CAGR-28.7%
Year-over-Year Change
Earnings before interest, taxes, depreciation, and amortization
3Y CAGR
-35.4%/yr
Annual compound
5Y CAGR
-28.7%/yr
Recent deceleration
Percentile
P64
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $13.18M | +33.4% |
| 2023 | $9.88M | -70.5% |
| 2022 | $33.53M | -31.3% |
| 2021 | $48.78M | -47.0% |
| 2020 | $92.11M | +28.9% |
| 2019 | $71.46M | +40.2% |
| 2018 | $50.98M | +228.1% |
| 2017 | $-39.81M | -186.9% |
| 2016 | $-13.88M | +5.9% |
| 2015 | $-14.75M | - |